Skip to main content
Clinical Trials/NCT04790526
NCT04790526
Completed
Not Applicable

Dose Response of Eccentric Exercises on Glycemic Control in Type ii Diabetes Mellitus

Riphah International University1 site in 1 country59 target enrollmentJuly 12, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type II Diabetes Mellitus
Sponsor
Riphah International University
Enrollment
59
Locations
1
Primary Endpoint
Glucometer
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The major aim of this project to check the dose response of eccentric exercise in reduction of glycemic index in type II Diabetes Mellitus. This study aim to check the effect of eccentric exercises on Glycemic index, quality of life, strength, exertion, balance and proprioception in type II Diabetes Mellitus patients

Detailed Description

From the last three decades, the diabetes mellitus progress quadrupled.The International Diabetes Federation (IDF) approximate that 1 in 11 adults with age between 20 to 79 years have diabetes mellitus. Almost 90 percent of patients diagnosed with Diabetes Mellitus are type 2 diabetes mellitus patients. According to the World Health Organization, Diabetes mellitus could be 7th leading cause of death. Type II Diabetes Mellitus (T2DM) increase progressively that affect around 25 million people in Europe and major public health issue for middle income countries. It is proposed that the prevalence of diabetes mellitus will increase up to 67% in middle-income countries from 2010 to 2030. In Pakistan, the Type II Diabetes Mellitus prevalence in 2018 is 11.77%. The prevalence is more in male as compared to females and urban area have 14.81 percent as compared to rural area. The genetic architecture might partially determine an individual's response to environmental changes.The risk factors of Type II Diabetes Mellitus include obesity, ageing, behavioral and environment factors, diet and lifestyle. School-age children had also warned of a rise in childhood obesity in Pakistan, which is considered a strong risk factor in diabetic patients. The major cause of Type II Diabetes Mellitus is deficiency or loss of insulin. Brain utilize glucose as source of energy and when brain is unable to maintain integrity, Many physiological mechanism initiates to reduce and limit the effect of hypoglycemia.The response of human body in reaction to reduce glucose level causes lowering the secretion of insulin and release counter-regulatory hormone.Diabetes mellitus have strong correlation for reduction in muscular strength and functional status. A recent study on global burden of diseases, Diabetes mellitus considered as ninth major cause of reduced life expectancy. A study conducted decades ago concluded that 3.96 million deaths occur due to diabetes mellitus with aged between 20-79 years. According to the International Diabetes Federation, the number and complications of diabetes mellitus increase rapidly up to 5.0 million deaths due to metabolic disorder.The prevalence of disability occurrence due to diabetes mellitus increase significantly since 3 decades ago. According to the global burden of Disease, Injuries and Risk factor statement, the 10th most common factor of disability was fasting level of glucose in 1990, 4th common cause till 2005 and 3rd common cause in 2015.45.8 percent of diabetes mellitus patients were approximately not diagnosed. Those patient who are not diagnosed have more risk of complication as compared to those who are diagnosed and start intervention. Medical expenditure of diabetes mellitus patients increases three times more than general population.The cases of people living suffering from Type II Diabetes Mellitus increase quadrupled between 1980 and 2014 globally. Adults who have diagnosed diabetes mellitus enhance to 20 percent from 2010 to 2030 and predicted to increase rapidly up to 69 percent. In Asia, the epidemic of Type II Diabetes Mellitus progress very rapidly and characterized by onset at a lower BMI and younger age than in Western populations. An average cost for the treatment of Diabetes Mellitus in Pakistan ranges from 650 to 20000 PKR.

Registry
clinicaltrials.gov
Start Date
July 12, 2021
End Date
May 25, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Cleared by a general practitioner to attend the training program Sedentary patients with controlled type 2 diabetes, according to the definition of the American Diabetes Association.
  • Participants were untrained and had not engaged in resistance or aerobic exercise within 6 months prior to beginning the study.
  • Age between 45-65 Years. BMI should be 18.5-34.9 kg/m2.

Exclusion Criteria

  • Participants with GIT disturbance (Gastroparesis and non-alcoholic fatty liver disease) will be excluded from the study.
  • Participants with any kind of Musculo-skeletal injury will be excluded from the study.
  • Participants with Stage II hypertension according to AHA guidelines. Participants who use tobacco products within the previous 6 months. Participants who take any type of systematic medication within the previous 6 months except diabetes.
  • Participants with any symptoms of neuropathy, retinopathy or nephropathy will be excluded

Outcomes

Primary Outcomes

Glucometer

Time Frame: 12 week

Glucometer will use to monitor glucose before and after the intervention. Glucometer have poor validity and reliability but consider medical tool for the management of diabetes.

HBA1c

Time Frame: 0 week and 12th week

The A1C test is the most common diagnostic and screening tool used for Type II Diabetes Mellitus (T2DM) management and research

Secondary Outcomes

  • BERG Balance Scale(0 week,4th week,8th week and 12th week)
  • WHO-QOL (BREF-Urdu version)(0 week,4th week,8th week and 12th week)
  • Dynamometer(0 week,4th week,8th week and 12th week)
  • Borg's Exertion Scale(0 week,4th week,8th week and 12th week)
  • Six Minutes' Walk Test(0 week,4th week,8th week and 12th week)
  • Joint error position test(0 week,4th week,8th week and 12th week)

Study Sites (1)

Loading locations...

Similar Trials